[go: up one dir, main page]

ATE371670T1 - Reinigung von neurotrophinen - Google Patents

Reinigung von neurotrophinen

Info

Publication number
ATE371670T1
ATE371670T1 AT97948362T AT97948362T ATE371670T1 AT E371670 T1 ATE371670 T1 AT E371670T1 AT 97948362 T AT97948362 T AT 97948362T AT 97948362 T AT97948362 T AT 97948362T AT E371670 T1 ATE371670 T1 AT E371670T1
Authority
AT
Austria
Prior art keywords
neurotrophins
purification
including mature
mature ngf
methods
Prior art date
Application number
AT97948362T
Other languages
English (en)
Inventor
Louis Burton
Charles Schmelzer
Joanne Beck
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE371670T1 publication Critical patent/ATE371670T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
AT97948362T 1996-11-15 1997-11-14 Reinigung von neurotrophinen ATE371670T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3083896P 1996-11-15 1996-11-15
US4785597P 1997-05-29 1997-05-29

Publications (1)

Publication Number Publication Date
ATE371670T1 true ATE371670T1 (de) 2007-09-15

Family

ID=26706516

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97948362T ATE371670T1 (de) 1996-11-15 1997-11-14 Reinigung von neurotrophinen

Country Status (21)

Country Link
US (5) US6005081A (de)
EP (1) EP0942930B1 (de)
JP (3) JP4671372B2 (de)
KR (1) KR100554332B1 (de)
CN (1) CN1268639C (de)
AT (1) ATE371670T1 (de)
AU (1) AU729459B2 (de)
BR (1) BR9713055A (de)
CA (1) CA2268747A1 (de)
CZ (1) CZ300296B6 (de)
DE (1) DE69738074T2 (de)
EA (1) EA002349B1 (de)
ES (1) ES2293662T3 (de)
HU (1) HU222666B1 (de)
ID (1) ID26697A (de)
IL (2) IL129851A0 (de)
NO (1) NO327149B1 (de)
NZ (1) NZ335207A (de)
PL (1) PL191400B1 (de)
TR (1) TR199901734T2 (de)
WO (1) WO1998021234A2 (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0942930B1 (de) * 1996-11-15 2007-08-29 Genentech, Inc. Reinigung von neurotrophinen
EP1032830A1 (de) * 1997-11-20 2000-09-06 ESA, Inc. Elektrochemisches analysesystem
KR100960211B1 (ko) * 1998-05-06 2010-05-27 제넨테크, 인크. 이온 교환 크로마토그래피에 의한 단백질 정제 방법
AU4951501A (en) 2000-03-27 2001-10-08 Genetics Inst Methods for purifying highly anionic proteins
ATE333469T1 (de) * 2001-06-05 2006-08-15 Genetics Inst Llc Verfahren zur reinigung hochanionischer proteine
WO2002102844A1 (en) * 2001-06-15 2002-12-27 Queensland Bioprocessing Technology Pty Ltd Haemocyanin from abalone and process of purification thereof
EP1545608A4 (de) 2002-06-28 2006-09-13 Centocor Inc Ch1-deletierte säugetier-mimetikörper, zusammensetzungen, verfahren und anwendungen
US7998705B2 (en) * 2002-08-06 2011-08-16 FUJIFILM Diosynth Biotechnologies U.S.A., Inc Increased dynamic binding capacity in ion exchange chromatography by addition of polyethylene glycol
AU2003902066A0 (en) * 2003-05-01 2003-05-15 Norika Holdings Extraction process for a pharmaceutical product
CA2487673C (en) * 2003-12-02 2010-11-02 F. Hoffmann-La Roche Ag Improved method for the recombinant production and purification of protein kinases
EP1538201A1 (de) * 2003-12-02 2005-06-08 F.Hoffmann-La Roche Ag Verfahren zur Herstellung und Reinigung von rekombinanten Proteinkinasen
WO2005082401A1 (en) * 2004-02-20 2005-09-09 Rinat Neuroscience Corp. Methods of treating obesity or diabetes using nt-4/5
PT2100904E (pt) * 2004-04-23 2010-09-24 Conjuchem Biotechnologies Inc Fase sólida para utilização num método para a purificação de conjugados de albumina
US8097584B2 (en) 2005-05-25 2012-01-17 Novo Nordisk A/S Stabilized formulations of insulin that comprise ethylenediamine
EP1888117A1 (de) * 2005-05-25 2008-02-20 Novo Nordisk A/S Stabilisierte polypetidformulierungen
SI1917276T1 (en) 2005-08-26 2018-05-31 Ares Trading S.A. PROCEDURE FOR PREPARATION OF GLYCOSYLATED INTERFERONE BETA
US8604175B2 (en) 2005-12-09 2013-12-10 Ares Trading S.A. Method for purifying FSH or a FSH mutant
CN100419422C (zh) * 2005-12-12 2008-09-17 北京三诺佳邑生物技术有限责任公司 测定神经生长因子含量的方法
AR058568A1 (es) 2005-12-20 2008-02-13 Bristol Myers Squibb Co Metodos para producir una composicion con moleculas ctla4-ig a partir de un medio de cultivo
JP5096369B2 (ja) 2005-12-20 2012-12-12 ブリストル−マイヤーズ スクイブ カンパニー 組成物および組成物の製造方法
RU2008131939A (ru) 2006-02-02 2010-02-10 Ринат Ньюросайенс Корп. (Us) Способы лечения нежелательной потери веса или нарушений приема пищи агонистами trkb
US7935342B2 (en) * 2006-02-02 2011-05-03 Rinat Neuroscience Corp. Methods for treating obesity by administering a trkB antagonist
US10741034B2 (en) 2006-05-19 2020-08-11 Apdn (B.V.I.) Inc. Security system and method of marking an inventory item and/or person in the vicinity
US9790538B2 (en) * 2013-03-07 2017-10-17 Apdn (B.V.I.) Inc. Alkaline activation for immobilization of DNA taggants
US20100086997A1 (en) * 2006-12-20 2010-04-08 Rinat Enuroscience Corp TrkB Agonists for Treating Autoimmune Disorders
HUE046992T2 (hu) 2007-07-09 2020-04-28 Genentech Inc Diszulfidkötés redukciójának megelõzése polipeptidek rekombináns elõállítása során
US20090148435A1 (en) 2007-10-30 2009-06-11 Genentech, Inc. Antibody purification by cation exchange chromatography
US8447409B2 (en) * 2008-10-15 2013-05-21 Cochlear Limited Electroneural interface for a medical implant
US20120269815A1 (en) * 2008-12-23 2012-10-25 Regents Of The University Of Minnesota Neurotrophins and uses thereof
JP5695384B2 (ja) 2009-10-05 2015-04-01 花王株式会社 毛髪形状感受性遺伝子
JP5699429B2 (ja) * 2009-12-18 2015-04-08 東ソー株式会社 Ｆｃレセプターの精製方法
SG181496A1 (en) 2009-12-18 2012-07-30 Csl Ltd Method of purifying polypeptides
EP2587265B1 (de) * 2010-06-25 2016-05-04 Nippon Zoki Pharmaceutical Co., Ltd. Verfahren zur bestimmung oder auswertung einer testsubstanz
CN102898514B (zh) * 2011-07-28 2015-04-29 中国人民解放军军事医学科学院生物工程研究所 重组人神经生长因子缺失突变体及其制备方法和用途
EP2594295A1 (de) 2011-11-16 2013-05-22 Servicio Andaluz De Salud Nervenimplantat basierend auf einem kompaktierten, zellhaltigen Biomaterial
US9297032B2 (en) 2012-10-10 2016-03-29 Apdn (B.V.I.) Inc. Use of perturbants to facilitate incorporation and recovery of taggants from polymerized coatings
US9266370B2 (en) 2012-10-10 2016-02-23 Apdn (B.V.I) Inc. DNA marking of previously undistinguished items for traceability
US9963740B2 (en) 2013-03-07 2018-05-08 APDN (B.V.I.), Inc. Method and device for marking articles
CA2926436A1 (en) 2013-10-07 2015-04-16 Judith Murrah Multimode image and spectral reader
CN103880943A (zh) * 2014-01-20 2014-06-25 厦门北大之路生物工程有限公司 一种rhNGF成熟肽的制备方法
US10745825B2 (en) 2014-03-18 2020-08-18 Apdn (B.V.I.) Inc. Encrypted optical markers for security applications
JP2017512692A (ja) 2014-03-18 2017-05-25 エーピーディーエヌ（ビー・ヴイ・アイ）・インコーポレイテッド セキュリティ用途のための暗号化された光学マーカー
CN104195160A (zh) * 2014-08-08 2014-12-10 厦门北大之路生物工程有限公司 一种以Pro-BDNF的形式制备人脑源性神经营养因子的方法
US10760182B2 (en) 2014-12-16 2020-09-01 Apdn (B.V.I.) Inc. Method and device for marking fibrous materials
CN106279397A (zh) * 2015-06-09 2017-01-04 舒泰神（北京）生物制药股份有限公司 一种神经生长因子的提取方法
CN109070130B (zh) 2016-04-11 2022-03-22 亚普蒂恩（B V I）公司 用于标记纤维素产品的方法
CN106478801A (zh) * 2016-10-10 2017-03-08 未名生物医药有限公司 一种从哺乳动物细胞培养物中分离重组人神经生长因子的方法
US10995371B2 (en) 2016-10-13 2021-05-04 Apdn (B.V.I.) Inc. Composition and method of DNA marking elastomeric material
WO2018156352A1 (en) 2017-02-21 2018-08-30 Apdn (B.V.I) Inc. Nucleic acid coated submicron particles for authentication
GB201705955D0 (en) * 2017-04-13 2017-05-31 Cell Guidance Systems Ltd Delivery method
CN107973848B (zh) * 2017-12-28 2020-10-16 未名生物医药有限公司 一种从混合物中分离天然序列神经生长因子的方法
CN108467429A (zh) * 2018-03-26 2018-08-31 江苏中新医药有限公司 疏水层析动态清除重组人神经生长因子前体的方法
CN108239146A (zh) * 2018-03-26 2018-07-03 江苏中新医药有限公司 一种高纯度rhNGF的制备方法
CN108467428A (zh) * 2018-03-26 2018-08-31 江苏中新医药有限公司 一种清除rhNGF中N端截短及异常变异体的方法
WO2019207106A1 (en) * 2018-04-27 2019-10-31 Chiesi Farmaceutici Spa Production of nerve growth factor (ngf) and of muteins thereof
CN114252519B (zh) * 2020-09-23 2023-11-24 舒泰神（北京）生物制药股份有限公司 一种测定神经生长因子纯度的方法
CN114380901A (zh) * 2021-12-31 2022-04-22 华东理工大学 蛋白纳米粒子的制备方法、所得蛋白纳米粒子及其应用

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4407744A (en) * 1977-11-23 1983-10-04 Young David M Process for obtaining nerve growth factor
US4565785A (en) * 1978-06-08 1986-01-21 The President And Fellows Of Harvard College Recombinant DNA molecule
US4673641A (en) * 1982-12-16 1987-06-16 Molecular Genetics Research And Development Limited Partnership Co-aggregate purification of proteins
DK161152C (da) * 1983-03-03 1991-11-11 Genentech Inc Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat
US5169762A (en) * 1983-03-03 1992-12-08 Genentech, Inc. Human nerve growth factor by recombinant technology
US4710473A (en) * 1983-08-10 1987-12-01 Amgen, Inc. DNA plasmids
US4738921A (en) * 1984-09-27 1988-04-19 Eli Lilly And Company Derivative of the tryptophan operon for expression of fused gene products
US4795706A (en) * 1985-01-31 1989-01-03 Eli Lilly And Company Novel expression control sequences
IT1219874B (it) * 1988-03-18 1990-05-24 Fidia Farmaceutici Utilizzazione del fattore di crescita nervoso umano e sue composizioni farmaceutiche
US5082774A (en) * 1988-08-30 1992-01-21 The General Hospital Corporation Recombinant human nerve growth factor
US5272063A (en) * 1988-11-22 1993-12-21 Syntex (U.S.A.) Inc. Process of making human nerve growth factor
CA2005600A1 (en) * 1988-12-20 1990-06-20 Cal-Henrik Heldin Endothelial cell growth factor
ATE119938T1 (de) * 1989-08-21 1995-04-15 Takeda Chemical Industries Ltd Produktion von menschlichen nervenwachstumsfaktoren.
JPH04128300A (ja) * 1989-08-21 1992-04-28 Takeda Chem Ind Ltd ヒト神経成長因子蛋白質およびその製造法
US5180820A (en) * 1989-08-30 1993-01-19 Barde Yves Alain Brain-derived neurotrophic factor
US5229500A (en) * 1989-08-30 1993-07-20 Regeneron Pharmaceuticals, Inc. Brain derived neurotrophic factor
US5606031A (en) * 1990-04-06 1997-02-25 Lile; Jack Production and purification of biologically active recombinant neurotrophic protein in bacteria
US5235043A (en) * 1990-04-06 1993-08-10 Synergen, Inc. Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins
US5169764A (en) * 1990-08-08 1992-12-08 Regeneron Pharmaceuticals, Inc. Multitrophic and multifunctional chimeric neurotrophic factors, and nucleic acids and plasmids encoding the chimeras
US5364769A (en) * 1990-09-25 1994-11-15 Genentech, Inc. Nucleic acid encoding neurotrophic factor four (NT-4), vectors, host cells and methods of production
WO1992005254A1 (en) * 1990-09-25 1992-04-02 Genentech, Inc. Novel neurothrophic factor
US5702906A (en) * 1990-09-25 1997-12-30 Genentech, Inc. Antibodies to neurotrophic factor-4 (NT-4)
DK0499993T3 (da) * 1991-02-18 1997-12-01 Takeda Chemical Industries Ltd Fremgangsmåde til fremstilling af human nervevækstfaktor-2
US5389529A (en) * 1991-06-12 1995-02-14 Regeneron Pharmaceuticals, Inc. Modified lamβ signal sequence and processes for producing recombinant neurotrophins
PT100580A (pt) * 1991-06-12 1993-09-30 Regeneron Pharma Producao e recuperacao de neurotrofinas recombinantes
DE4133707A1 (de) * 1991-10-11 1993-04-15 Behringwerke Ag Verfahren zur reinigung von streptolysin o, intaktes streptolysin o erhaeltlich nach diesem verfahren und seine verwendung
JPH05211887A (ja) * 1992-01-31 1993-08-24 Hitachi Ltd 神経成長因子の生産方法
US5349055A (en) * 1992-03-06 1994-09-20 Persson Hakan B Nerve growth factor having altered receptor binding specificities
US5488099A (en) * 1992-03-06 1996-01-30 Persson, Deceased; Hakan B. Multifunctional chimeric neurotrophic factors
US5451660A (en) * 1993-12-13 1995-09-19 Genentech, Inc. Method for purifying polypeptides
US5728803A (en) * 1994-06-03 1998-03-17 Genentech, Inc. Pantropic neurotrophic factors
US5798448A (en) * 1994-10-27 1998-08-25 Genentech, Inc. AL-1 neurotrophic factor antibodies
US5733875A (en) * 1994-11-15 1998-03-31 Amgen Inc. Methods of using GDNF as a neuroprotective agent
US5650496A (en) * 1995-04-14 1997-07-22 Cephalon, Inc. IGF-I purification process
IL118201A (en) * 1995-05-11 2004-12-15 Roche Diagnostics Gmbh Preparation comprising a protein with human erythropoietin activity which is free of serum and non-recombinant mammalian protein and process for the preparation thereof
US5739307A (en) * 1995-08-28 1998-04-14 Washington University Polynucleotide encoding neurturin neurotrophic factor
EP0942930B1 (de) * 1996-11-15 2007-08-29 Genentech, Inc. Reinigung von neurotrophinen

Also Published As

Publication number Publication date
JP2007302679A (ja) 2007-11-22
IL129851A (en) 2006-12-10
PL333460A1 (en) 1999-12-20
US20040138431A1 (en) 2004-07-15
KR20000053297A (ko) 2000-08-25
US6953844B2 (en) 2005-10-11
JP4671372B2 (ja) 2011-04-13
EP0942930B1 (de) 2007-08-29
NO992353D0 (no) 1999-05-14
IL129851A0 (en) 2000-02-29
JP2009040786A (ja) 2009-02-26
US20020137893A1 (en) 2002-09-26
AU5444898A (en) 1998-06-03
AU729459B2 (en) 2001-02-01
EP0942930A2 (de) 1999-09-22
US6812330B2 (en) 2004-11-02
WO1998021234A2 (en) 1998-05-22
KR100554332B1 (ko) 2006-02-24
DE69738074D1 (de) 2007-10-11
JP4881234B2 (ja) 2012-02-22
ES2293662T3 (es) 2008-03-16
CN1268639C (zh) 2006-08-09
US6005081A (en) 1999-12-21
TR199901734T2 (xx) 2000-01-21
HUP9903947A3 (en) 2001-03-28
CZ166699A3 (cs) 1999-10-13
US6423831B1 (en) 2002-07-23
PL191400B1 (pl) 2006-05-31
US6184360B1 (en) 2001-02-06
HUP9903947A2 (hu) 2000-03-28
EA002349B1 (ru) 2002-04-25
NZ335207A (en) 2000-09-29
BR9713055A (pt) 2000-04-04
CA2268747A1 (en) 1998-05-22
ID26697A (id) 2001-02-01
WO1998021234A3 (en) 1998-07-23
JP2001503779A (ja) 2001-03-21
NO992353L (no) 1999-07-09
CZ300296B6 (cs) 2009-04-15
DE69738074T2 (de) 2008-05-21
EA199900436A1 (ru) 2000-02-28
HU222666B1 (hu) 2003-09-29
NO327149B1 (no) 2009-05-04
CN1237184A (zh) 1999-12-01

Similar Documents

Publication Publication Date Title
ATE371670T1 (de) Reinigung von neurotrophinen
NO963239L (no) Klorpyrimid-mellomprodukter
TR199901174T2 (xx) Yeni heterosiklilmetil-ikameli pirazol t�revleri.
TR200200785T2 (tr) 8-Fenil-6,9-dihidro-[1,2,4] triazolo [3,4-i] purin-5-on türevleri
ID21235A (id) Produksi para-xylen terselektif oleh metilasi toluen
TR200102800T2 (tr) Yeni bileşikler.
TR199901305T2 (xx) Calpain-�nleyicileri olarak ketonbenzamidler
ID23374A (id) Halogenopirimidin
PT1017659E (pt) Tetra-hidronaftalenos substituidos e compostos analogos
DK0767798T3 (da) Sterolderivater anvendt til regulering af meiose
TR199802394A3 (tr) Proteinleri stabilize etmek için gelistirilmis proses.
FI931332A0 (fi) Uusia alkyleenidiammoniumdiklavulanaattijohdannaisia, menetelmä niidenvalmistamiseksi samoin kuin niiden käyttö kalvulaanihapon puhdistamiseksi
PT915819E (pt) Analogos de iludina uteis como agentes anti-tumorais
YU63696A (sh) Novi fenilamidin-derivati, postupci za njihovo pripremanje i njihova primena kao lekova
EP1242050A4 (de) Förderung der angiogenese durch survivin
SE9604582D0 (sv) Novel compounds
IT1278034B1 (it) Apaprecchio per il controllo del peso di sigarette.
DE3873278D1 (de) Aryl-substituierte thiophen-3-ole, ihre derivate und analoge als lipoxygenase-inhibitoren.
FI903680A0 (fi) Bilhjul med gott faeste.
DE69703115D1 (de) Zwischenprodukte um 2-imidazolin-5onederivate herzustellen.
ZA983231B (en) Substituted benzyloxyimino compounds.
ATE265418T1 (de) Neue substituierte 3-phenoxy- und 3- phenylalkyloxy-2-phenyl-propylamine
PT851856E (pt) Derivados de indolo como analogos melatoninergicos
MX9704836A (es) Proceso para la fabricaciom de acetonilbenzamidas.
NO962850D0 (no) Apparat for innretning av to deler

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0942930

Country of ref document: EP